• image description

    Nova TheraNostics brightens MRI images

    By Eran Moore Rea It was a surprise. Dr. Rodney Ho, UW professor of pharmaceutics, researches drug delivery for HIV treatment. In 2009, he created a new way to deliver HIV drugs to patients. HIV drugs rarely make it effectively to a patient’s lymph nodes. Ho thought binding the drugs to lipid (fatty particle) nanoparticles might help drug delivery. He eventually tested his drugs inView More

  • image description

    Professor to CEO and back again: Q & A with Dr. Vikram Jandhyala

    By Eran Moore Rea Vikram Jandhyala knows success in two worlds: business and academia. In 2006, he took a leave of absence from his professorship at UW to lead his start-up company, Nimbic. He returned to UW in 2009 and he has chaired the UW Electrical Engineering department since 2011. He now directs the UW Department of Electrical Engineering’s Applied Computational Engineering (ACE) Lab. HeView More

  • image description

    UW Researchers Improve Spirometry Testing and Asthma Care for Kids

    Spirometry, the measuring of breath, is the most common of the pulmonary function tests (PFTs), measuring lung function, and an important tool for assessing conditions such as asthma. Properly performed diagnostic spirometry and its correct interpretation are typically missing in primary care, and there are increasing calls for widespread training efforts to mitigate this deficiency. University of Washington researchers developed a suite of online resourcesView More

  • image description

    Breakthrough Test for Bone Loss Stands Test of Time

    More than 10 million adults in the United States have osteoporosis — weak, brittle bones vulnerable to fracture. Another 35 million have low bone density that can progress to osteoporosis. Health care costs for osteoporosis-related fractures total about $20 billion annually in the U.S., and are rising with our aging population. Most people have no symptoms of the disease and may receive no treatment toView More

  • image description

    Neurosurgeon and Bioengineer Aim for Paradigm Shift in Treatment of Hydrocephalus

    Advances in medical technology and surgical techniques have dramatically improved diagnosis and treatment of most disorders, saving and extending lives. Yet the technology revolution has bypassed a simple device used for 50 years to treat a relatively common but devastating condition in newborns — hydrocephalus, the excess accumulation of cerebrospinal fluid in the brain. If this fluid is not continuously drained through a catheter and shunt system, the pressure buildup can damage brain tissue and expand the skull bones leading to fatal consequences. Continue reading View More

  • Dance Method DVD Expands a Teacher’s Audience

    “When are you going to make a video?” is a question Jennifer Salk, MFA, associate professor in the University of Washington dance program would get often from dance teachers attending her master classes and workshops. An expert in weaving anatomy instruction into dance technique classes, Salk has taught at the American Dance Festival, the International Association for Dance Medicine and Science, and National Dance EducationView More

  • image description

    Start-up Company Focuses on New Approach to Treating Cancer

    When Professor André Lieber first disclosed his novel approach to cancer therapy in 2008, C4C technology manager Angela Loihl immediately recognized it could be “a winner.” Lieber’s team is the only one in the world working to block the action of a key cell surface receptor, CD46, a protein that is active in tumor cells and protects them from being killed by antibodies. The recombinantView More

  • image description

    Fate Therapeutics Charts Destiny to World-Leading Stem Cell Company

    Fate Therapeutics is a three-year-old life sciences start-up with fewer than 50 employees, but it has already won high-profile attention. Earlier this year MIT’s Technology Review cited Fate as one of the 50 most innovative companies in the world—alongside Apple, GlaxoSmithKline, and Tesla Motors—for its promising approach to stem cell therapy. And Fate was conceived at UW. Unlike companies that work with embryonic stem cells,View More

  • image description

    Research could lead to more accurate testing for coronary artery disease

    Some 150 million blood lipid panels are done annually in the U.S. to assess levels of cholesterol, high-density (HDL “good”) and low-density (LDL “bad”) lipoproteins, and other substances that affect risk for coronary artery disease – the leading cause of death in the U.S. For the 80 percent of the population with levels in a broad range of normal, these tests are as accurate inView More

  • image description

    Clinic’s pilot project taps into health care system inefficiencies

    America’s health care system is regularly in the news, with calls for increasing efficiency and effectiveness, expanding access, and reigning in escalating costs. Every health care dollar must be spent responsibly. Mental health and substance abuse problems affect one in four adults in the U.S. each year, and providers seek ways to demonstrate the effectiveness of their interventions to consumers, agencies, and third-party payers. AView More